Italian Association Amici di Raoul Follereau (AIFO)

Contact

General

Project Support

Alliances & Links

Resources & Training

ARCHIVES OF LEPROSY MAILING LIST
Archives of recent messages from Leprosy Mailing List (LML) managed by Dr Salvatore Noto.

Over the past few years, LML moderated by Dr Noto has become one of the most important online resource for promoting discussions about leprosy.

Contact LML Objectives of LML LML Archives

Leprosy Mailing List – December 11th, 2007

 

Ref.:     Dapsone, a major component of an anti-vitiligo treatment regimen

From:   Salafia A., Mumbai, India


 

Dear Salvatore,

 

This has reference to the statement of Dr. Narisamha Rao (LML December 7th, 2007).  More than a statement, this sounds like a Supreme Court judgment: "Dapsone is useless in Vitiligo. Sentence passed. No appeal".  I do not agree.


Dapsone in Vitiligo was used, for the first time, in a Leprosy Hospital in Eluru, Andhra Pradesh, India and, the first paper on the subject came from Andhra Pradesh too.


This is a Leprosy Forum, and not Vitiligo, so I cannot exceed my briefing, but a few references are a must, lest the readers may think that my statements are baseless. The facts:

1.
It is an accepted fact that the skin of Vitiligo patients has a higher level of Sulphydryl groups (Cysteine and Glutathione), and we know that the Sulphydryl groups are responsible for diverting the process of melanin formation towards the Pheomelanins (which are the white pigments) at the expenses of the Eumelanins. References:

1.a.
Van Scott E.J. Flesch P.:  Sulphydryl groups and disulfide linkages in normal and pathological keratinization. Arch. Dermat Syph. 70:141 (1954)

1.b.
Rao D.S., Susheela A.K., Pandhi P.K. et alias:  Tissue sulphydryl groups and ascorbic acid in Vitiligo. 
Ind. Journ  Dermat Ven Lepr. 45; 274-276. (1979)

2.

It is a fact that Dapsone reduces the levels of Glutathione and Cysteine in blood. References:

2.a.

Desforges J.F., Thayer W.W.,Dawson J.P.:  Hemolityc anemia induced by sulfoxone therapy, with investigations into the mechanism of its production.  Am J. Med. 27 :132-136. (1959)

2.b.
Rasbridge M.R., Scott G.L.:  The Hemolytic action of Dapsone; the effect on red cell glucolysis. Br. J. Haem 24; 169-181.(1973)


An Italian Journals, Chronica Dermatologica (the most authoritative Italian Journal on Dermatology) has published -IN ENGLISH LANGUAGE- the following article:-

Salafia A.  Successful treatment of Vitiligo with Dapsone.  Review of 5601 cases.  Chronica Dermatologica.  Vol. V pg. 171-187. (1995).  Today, in Mumbai, the cases we have treated are more than 15 thousand.


The whole story of Vitiligo and its treatment is a complex one and I cannot do justice to it in a short note; at any rate, Dapsone is the major component of our treatment, which includes Copper Sulphate, Folic acid, Iron Sulphate and Vitamin B6 in high dosage.  The junior dermatologists who work with me at Vimala Dermatological Centre, initially are sceptic about the use of Dapsone, but, once they see the results (and hear the patients comments) they too adopt it.

 

I can give sufficient references to show the value of Dapsone in vitiligo; moreover at Vimala Dermatological Centre we have tried therapies with and without Dapsone, and have noted a marked difference in the outcome of the disease when Dapsone is added to Copper, Folic acid, Iron, and Vitamin B6.  It has to be tried not only on those cases which are notorious for been difficult to treat (like malleoli and fingers).  It is a fact that we are using dapsone from 1985 (circa) till today and we (the patients too!) find it useful in very low dosages like 50 mgs 3 times a week.

My last word: those who are interested in this regimen, can kindly get in contact directly with me and I will send them my book on Vitiligo (published in January 2004) with the full story.
 
I thank you for allowing me to clarify my views on Dapsone.


Antonio Salafia

 

 

<< BACK TO LML ARCHIVE INDEX

 

AIFO, Via Borselli 4-6, 40135 Bologna, Italy
Tel: +390-51-4393.211 Fax: +390-51-434046 Email: info@aifo.it